Report Detail
COVID-19 Impact on Global TDS(Transdermal Delivery Systems) Market Insights, Forecast to 2026
- RnM4068833 |
- 18 June, 2020 |
- Global |
- 113 Pages |
- QYResearch |
- Pharma & Healthcare
TDS(Transdermal Delivery Systems) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global TDS(Transdermal Delivery Systems) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the TDS(Transdermal Delivery Systems) market is segmented into
Single-layer Drug-in-Adhesive
Multi-layer Drug-in-Adhesive
Others
Segment by Application, the TDS(Transdermal Delivery Systems) market is segmented into
Hospital
Clinic
Other
Regional and Country-level Analysis
The TDS(Transdermal Delivery Systems) market is analysed and market size information is provided by regions (countries).
The key regions covered in the TDS(Transdermal Delivery Systems) market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and TDS(Transdermal Delivery Systems) Market Share Analysis
TDS(Transdermal Delivery Systems) market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in TDS(Transdermal Delivery Systems) business, the date to enter into the TDS(Transdermal Delivery Systems) market, TDS(Transdermal Delivery Systems) product introduction, recent developments, etc.
The major vendors covered:
Adhex Pharma
Harro Hofliger
Tesa Labtec
Toyochem
Teva Pharmaceutical
Pfizer
IBSA Group
Teikoku Seiyaku
Endo International
Hisamitsu
Mylan
Sorrento Therapeutics
1 Study Coverage
- 1.1 TDS(Transdermal Delivery Systems) Product Introduction
- 1.2 Market Segments
- 1.3 Key TDS(Transdermal Delivery Systems) Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global TDS(Transdermal Delivery Systems) Market Size Growth Rate by Type
- 1.4.2 Single-layer Drug-in-Adhesive
- 1.4.3 Multi-layer Drug-in-Adhesive
- 1.4.4 Others
- 1.5 Market by Application
- 1.5.1 Global TDS(Transdermal Delivery Systems) Market Size Growth Rate by Application
- 1.5.2 Hospital
- 1.5.3 Clinic
- 1.5.4 Other
- 1.6 Coronavirus Disease 2019 (Covid-19): TDS(Transdermal Delivery Systems) Industry Impact
- 1.6.1 How the Covid-19 is Affecting the TDS(Transdermal Delivery Systems) Industry
- 1.6.1.1 TDS(Transdermal Delivery Systems) Business Impact Assessment - Covid-19
- 1.6.1.2 Supply Chain Challenges
- 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
- 1.6.2 Market Trends and TDS(Transdermal Delivery Systems) Potential Opportunities in the COVID-19 Landscape
- 1.6.3 Measures / Proposal against Covid-19
- 1.6.3.1 Government Measures to Combat Covid-19 Impact
- 1.6.3.2 Proposal for TDS(Transdermal Delivery Systems) Players to Combat Covid-19 Impact
- 1.6.1 How the Covid-19 is Affecting the TDS(Transdermal Delivery Systems) Industry
- 1.7 Study Objectives
- 1.8 Years Considered
2 Executive Summary
- 2.1 Global TDS(Transdermal Delivery Systems) Market Size Estimates and Forecasts
- 2.1.1 Global TDS(Transdermal Delivery Systems) Revenue 2015-2026
- 2.1.2 Global TDS(Transdermal Delivery Systems) Sales 2015-2026
- 2.2 TDS(Transdermal Delivery Systems) Market Size by Region: 2020 Versus 2026
- 2.2.1 Global TDS(Transdermal Delivery Systems) Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global TDS(Transdermal Delivery Systems) Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global TDS(Transdermal Delivery Systems) Competitor Landscape by Players
- 3.1 TDS(Transdermal Delivery Systems) Sales by Manufacturers
- 3.1.1 TDS(Transdermal Delivery Systems) Sales by Manufacturers (2015-2020)
- 3.1.2 TDS(Transdermal Delivery Systems) Sales Market Share by Manufacturers (2015-2020)
- 3.2 TDS(Transdermal Delivery Systems) Revenue by Manufacturers
- 3.2.1 TDS(Transdermal Delivery Systems) Revenue by Manufacturers (2015-2020)
- 3.2.2 TDS(Transdermal Delivery Systems) Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global TDS(Transdermal Delivery Systems) Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by TDS(Transdermal Delivery Systems) Revenue in 2019
- 3.2.5 Global TDS(Transdermal Delivery Systems) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 TDS(Transdermal Delivery Systems) Price by Manufacturers
- 3.4 TDS(Transdermal Delivery Systems) Manufacturing Base Distribution, Product Types
- 3.4.1 TDS(Transdermal Delivery Systems) Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers TDS(Transdermal Delivery Systems) Product Type
- 3.4.3 Date of International Manufacturers Enter into TDS(Transdermal Delivery Systems) Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
- 4.1 Global TDS(Transdermal Delivery Systems) Market Size by Type (2015-2020)
- 4.1.1 Global TDS(Transdermal Delivery Systems) Sales by Type (2015-2020)
- 4.1.2 Global TDS(Transdermal Delivery Systems) Revenue by Type (2015-2020)
- 4.1.3 TDS(Transdermal Delivery Systems) Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global TDS(Transdermal Delivery Systems) Market Size Forecast by Type (2021-2026)
- 4.2.1 Global TDS(Transdermal Delivery Systems) Sales Forecast by Type (2021-2026)
- 4.2.2 Global TDS(Transdermal Delivery Systems) Revenue Forecast by Type (2021-2026)
- 4.2.3 TDS(Transdermal Delivery Systems) Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global TDS(Transdermal Delivery Systems) Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
- 5.1 Global TDS(Transdermal Delivery Systems) Market Size by Application (2015-2020)
- 5.1.1 Global TDS(Transdermal Delivery Systems) Sales by Application (2015-2020)
- 5.1.2 Global TDS(Transdermal Delivery Systems) Revenue by Application (2015-2020)
- 5.1.3 TDS(Transdermal Delivery Systems) Price by Application (2015-2020)
- 5.2 TDS(Transdermal Delivery Systems) Market Size Forecast by Application (2021-2026)
- 5.2.1 Global TDS(Transdermal Delivery Systems) Sales Forecast by Application (2021-2026)
- 5.2.2 Global TDS(Transdermal Delivery Systems) Revenue Forecast by Application (2021-2026)
- 5.2.3 Global TDS(Transdermal Delivery Systems) Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America TDS(Transdermal Delivery Systems) by Country
- 6.1.1 North America TDS(Transdermal Delivery Systems) Sales by Country
- 6.1.2 North America TDS(Transdermal Delivery Systems) Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America TDS(Transdermal Delivery Systems) Market Facts & Figures by Type
- 6.3 North America TDS(Transdermal Delivery Systems) Market Facts & Figures by Application
7 Europe
- 7.1 Europe TDS(Transdermal Delivery Systems) by Country
- 7.1.1 Europe TDS(Transdermal Delivery Systems) Sales by Country
- 7.1.2 Europe TDS(Transdermal Delivery Systems) Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe TDS(Transdermal Delivery Systems) Market Facts & Figures by Type
- 7.3 Europe TDS(Transdermal Delivery Systems) Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific TDS(Transdermal Delivery Systems) by Region
- 8.1.1 Asia Pacific TDS(Transdermal Delivery Systems) Sales by Region
- 8.1.2 Asia Pacific TDS(Transdermal Delivery Systems) Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific TDS(Transdermal Delivery Systems) Market Facts & Figures by Type
- 8.3 Asia Pacific TDS(Transdermal Delivery Systems) Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America TDS(Transdermal Delivery Systems) by Country
- 9.1.1 Latin America TDS(Transdermal Delivery Systems) Sales by Country
- 9.1.2 Latin America TDS(Transdermal Delivery Systems) Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America TDS(Transdermal Delivery Systems) Market Facts & Figures by Type
- 9.3 Central & South America TDS(Transdermal Delivery Systems) Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa TDS(Transdermal Delivery Systems) by Country
- 10.1.1 Middle East and Africa TDS(Transdermal Delivery Systems) Sales by Country
- 10.1.2 Middle East and Africa TDS(Transdermal Delivery Systems) Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa TDS(Transdermal Delivery Systems) Market Facts & Figures by Type
- 10.3 Middle East and Africa TDS(Transdermal Delivery Systems) Market Facts & Figures by Application
11 Company Profiles
- 11.1 Adhex Pharma
- 11.1.1 Adhex Pharma Corporation Information
- 11.1.2 Adhex Pharma Description, Business Overview and Total Revenue
- 11.1.3 Adhex Pharma Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Adhex Pharma TDS(Transdermal Delivery Systems) Products Offered
- 11.1.5 Adhex Pharma Recent Development
- 11.2 Harro Hofliger
- 11.2.1 Harro Hofliger Corporation Information
- 11.2.2 Harro Hofliger Description, Business Overview and Total Revenue
- 11.2.3 Harro Hofliger Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 Harro Hofliger TDS(Transdermal Delivery Systems) Products Offered
- 11.2.5 Harro Hofliger Recent Development
- 11.3 Tesa Labtec
- 11.3.1 Tesa Labtec Corporation Information
- 11.3.2 Tesa Labtec Description, Business Overview and Total Revenue
- 11.3.3 Tesa Labtec Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 Tesa Labtec TDS(Transdermal Delivery Systems) Products Offered
- 11.3.5 Tesa Labtec Recent Development
- 11.4 Toyochem
- 11.4.1 Toyochem Corporation Information
- 11.4.2 Toyochem Description, Business Overview and Total Revenue
- 11.4.3 Toyochem Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 Toyochem TDS(Transdermal Delivery Systems) Products Offered
- 11.4.5 Toyochem Recent Development
- 11.5 Teva Pharmaceutical
- 11.5.1 Teva Pharmaceutical Corporation Information
- 11.5.2 Teva Pharmaceutical Description, Business Overview and Total Revenue
- 11.5.3 Teva Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Teva Pharmaceutical TDS(Transdermal Delivery Systems) Products Offered
- 11.5.5 Teva Pharmaceutical Recent Development
- 11.6 Pfizer
- 11.6.1 Pfizer Corporation Information
- 11.6.2 Pfizer Description, Business Overview and Total Revenue
- 11.6.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 Pfizer TDS(Transdermal Delivery Systems) Products Offered
- 11.6.5 Pfizer Recent Development
- 11.7 IBSA Group
- 11.7.1 IBSA Group Corporation Information
- 11.7.2 IBSA Group Description, Business Overview and Total Revenue
- 11.7.3 IBSA Group Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 IBSA Group TDS(Transdermal Delivery Systems) Products Offered
- 11.7.5 IBSA Group Recent Development
- 11.8 Teikoku Seiyaku
- 11.8.1 Teikoku Seiyaku Corporation Information
- 11.8.2 Teikoku Seiyaku Description, Business Overview and Total Revenue
- 11.8.3 Teikoku Seiyaku Sales, Revenue and Gross Margin (2015-2020)
- 11.8.4 Teikoku Seiyaku TDS(Transdermal Delivery Systems) Products Offered
- 11.8.5 Teikoku Seiyaku Recent Development
- 11.9 Endo International
- 11.9.1 Endo International Corporation Information
- 11.9.2 Endo International Description, Business Overview and Total Revenue
- 11.9.3 Endo International Sales, Revenue and Gross Margin (2015-2020)
- 11.9.4 Endo International TDS(Transdermal Delivery Systems) Products Offered
- 11.9.5 Endo International Recent Development
- 11.10 Hisamitsu
- 11.10.1 Hisamitsu Corporation Information
- 11.10.2 Hisamitsu Description, Business Overview and Total Revenue
- 11.10.3 Hisamitsu Sales, Revenue and Gross Margin (2015-2020)
- 11.10.4 Hisamitsu TDS(Transdermal Delivery Systems) Products Offered
- 11.10.5 Hisamitsu Recent Development
- 11.1 Adhex Pharma
- 11.1.1 Adhex Pharma Corporation Information
- 11.1.2 Adhex Pharma Description, Business Overview and Total Revenue
- 11.1.3 Adhex Pharma Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Adhex Pharma TDS(Transdermal Delivery Systems) Products Offered
- 11.1.5 Adhex Pharma Recent Development
- 11.12 Sorrento Therapeutics
- 11.12.1 Sorrento Therapeutics Corporation Information
- 11.12.2 Sorrento Therapeutics Description, Business Overview and Total Revenue
- 11.12.3 Sorrento Therapeutics Sales, Revenue and Gross Margin (2015-2020)
- 11.12.4 Sorrento Therapeutics Products Offered
- 11.12.5 Sorrento Therapeutics Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 TDS(Transdermal Delivery Systems) Market Estimates and Projections by Region
- 12.1.1 Global TDS(Transdermal Delivery Systems) Sales Forecast by Regions 2021-2026
- 12.1.2 Global TDS(Transdermal Delivery Systems) Revenue Forecast by Regions 2021-2026
- 12.2 North America TDS(Transdermal Delivery Systems) Market Size Forecast (2021-2026)
- 12.2.1 North America: TDS(Transdermal Delivery Systems) Sales Forecast (2021-2026)
- 12.2.2 North America: TDS(Transdermal Delivery Systems) Revenue Forecast (2021-2026)
- 12.2.3 North America: TDS(Transdermal Delivery Systems) Market Size Forecast by Country (2021-2026)
- 12.3 Europe TDS(Transdermal Delivery Systems) Market Size Forecast (2021-2026)
- 12.3.1 Europe: TDS(Transdermal Delivery Systems) Sales Forecast (2021-2026)
- 12.3.2 Europe: TDS(Transdermal Delivery Systems) Revenue Forecast (2021-2026)
- 12.3.3 Europe: TDS(Transdermal Delivery Systems) Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific TDS(Transdermal Delivery Systems) Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: TDS(Transdermal Delivery Systems) Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: TDS(Transdermal Delivery Systems) Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: TDS(Transdermal Delivery Systems) Market Size Forecast by Region (2021-2026)
- 12.5 Latin America TDS(Transdermal Delivery Systems) Market Size Forecast (2021-2026)
- 12.5.1 Latin America: TDS(Transdermal Delivery Systems) Sales Forecast (2021-2026)
- 12.5.2 Latin America: TDS(Transdermal Delivery Systems) Revenue Forecast (2021-2026)
- 12.5.3 Latin America: TDS(Transdermal Delivery Systems) Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa TDS(Transdermal Delivery Systems) Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: TDS(Transdermal Delivery Systems) Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: TDS(Transdermal Delivery Systems) Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: TDS(Transdermal Delivery Systems) Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter’s Five Forces Analysis
- 13.5 Primary Interviews with Key TDS(Transdermal Delivery Systems) Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 TDS(Transdermal Delivery Systems) Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
Summary:
Get latest Market Research Reports on COVID-19 Impact on Global TDS(Transdermal Delivery Systems). Industry analysis & Market Report on COVID-19 Impact on Global TDS(Transdermal Delivery Systems) is a syndicated market report, published as COVID-19 Impact on Global TDS(Transdermal Delivery Systems) Market Insights, Forecast to 2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global TDS(Transdermal Delivery Systems) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
